Recall

II Ongoing

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Why: Failed Dissolution Specifications: below specification

Company
Ajanta Pharma USA Inc
Bridgewater, NJ, United States
Reported
Oct 7, 2026
Recall started
Sep 17, 2026
Where sold
Nationwide in the US.
Amount
Full description
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Lots / codes affected
Lot: DJ25134, Exp 11/30/2028

Class I: could cause serious harm or death. Class II: temporary or treatable problems. Class III: unlikely to cause harm.